The pharmaceutical industry is expansive, comprising of development, production, and marketing subfields, and is regulated by several international bodies. Many of Scalar’s team have backgrounds in the medical field, giving them an in-depth understanding of the industry’s regulations and enabling them to provide experienced, insightful valuations.
Scalar engagement examples:
- Performed a fairness opinion for a $250 million merger between two publicly traded pharma companies
- Valued a $150 million company for gift and estate purposes
- Estimated an enterprise valuation range for a $500 million pharma company in South Korea